Measurement of bone mineral density as an efficacy marker in denosumab treatment of giant cell tumour of bone

Three patients with giant cell tumour of bone (GCTB) in the lower extremity, where the only surgical treatment options were amputation or severe weakening of the bone, were treated with denosumab (D-mab) to strengthen the bone mass in the tumour. In order to quantify changes in bone mineral density...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Case Rep
Hauptverfasser: Veng, Christian, Jørgensen, Peter Holmberg, Krog-Mikkelsen, Inger, Stilling, Maiken
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2017
Schlagworte:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5665203/
https://ncbi.nlm.nih.gov/pubmed/29066635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-220369
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge